Holen Sie sich die Stockscreener-App
8.40
11.11%
0.84
Handel nachbörslich:
8.24
-0.16
-1.90%
Schlusskurs vom Vortag:
$7.56
Offen:
$6.7
24-Stunden-Volumen:
588.69K
Relative Volume:
1.66
Marktkapitalisierung:
$396.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+54.13%
1M Leistung:
+42.61%
6M Leistung:
+70.04%
1J Leistung:
+0.00%
1-Tages-Spanne:
$6.70
$8.50
1-Wochen-Bereich:
$5.21
$8.50
52-Wochen-Spanne:
$3.50
$14.30
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Vergleichen Sie ZYBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
8.40 | 254.97M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
152.44 | 66.38B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 46.20B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Zhengye Biotechnology Holding Ltd Aktie (ZYBT) Neueste Nachrichten
Using Python tools to backtest Zhengye Biotechnology Holding Limited strategiesMarket Performance Report & Free Accurate Trade Setup Notifications - Newser
What machine learning models say about Zhengye Biotechnology Holding LimitedJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Published on: 2025-08-12 21:12:59 - Newser
Can Zhengye Biotechnology Holding Limited recover in the next quarterSummary of Consistent Growth Stock Picks - Newser
What’s the MACD signal for Zhengye Biotechnology Holding LimitedDaily Market Pulse Highlights - thegnnews.com
Will earnings trigger a reversal in Zhengye Biotechnology Holding LimitedHigh Yield Signals with Entry Timing - Newser
Technical signs of recovery in Zhengye Biotechnology Holding LimitedFree Short Term Buy List With Stop Protection - Newser
Will Zhengye Biotechnology Holding Limited rebound enough to break evenFree Trend Following Strategy With Stop Loss - Newser
Can COF.PRJ recover in the next quarterWeekly Setup Summary for Risk Controlled Trades - Newser
Fiverr International Ltd. stock outlook for YEARWeekly Outlook for Short Term Investors - Newser
How to interpret RSI for PDFS stockDeep Stock Performance and Volatility Analysis - Newser
SOTK stock prediction for this weekSwing Trade Timing with Daily Forecast - Newser
Multi factor analysis applied to GNSSEntry Zone Forecast for Momentum Trading - Newser
What catalysts could drive Zhengye Biotechnology Holding Limited stock higher in 2025Over 200% growth - Jammu Links News
What institutional investors are buying Zhengye Biotechnology Holding Limited stockPhenomenal capital appreciation - Jammu Links News
What is the risk reward ratio of investing in Zhengye Biotechnology Holding Limited stockMaximize portfolio value with timely trades - Jammu Links News
What are the latest earnings results for Zhengye Biotechnology Holding LimitedUnbelievable profit margins - Jammu Links News
Why Zhengye Biotechnology Holding Limited stock attracts strong analyst attentionMarket Timing Strategy with Technical Filters - newser.com
What is the dividend policy of Zhengye Biotechnology Holding Limited stockCapitalize on strong market momentum - Jammu Links News
Zhengye Biotechnology (NASDAQ:ZYBT) Raised to Hold at Wall Street Zen - Defense World
How strong is Zhengye Biotechnology Holding Limited company’s balance sheetAI Powered Forecasts With Proven Results - Jammu Links News
Price momentum metrics for Zhengye Biotechnology Holding Limited explainedLong-Term Growth Trend Summary With Confidence - Newser
What makes Zhengye Biotechnology Holding Limited stock price move sharply3-Day Market Movement Forecast Analysis - Newser
Zhengye Biotechnology Holding Limited stock daily chart insightsWeekly Hot Stocks Based on Volume Flow - Newser
Using economic indicators to assess Zhengye Biotechnology Holding Limited potentialEntry Confirmation Using Short-Term Forecasting - Newser
Combining machine learning predictions for Zhengye Biotechnology Holding LimitedFree Trade Setups With Clear Risk Limits - Newser
How does Zhengye Biotechnology Holding Limited generate profit in a changing economyPost Market Target Finder For Every Investor - jammulinksnews.com
What is Zhengye Biotechnology Holding Limited company’s growth strategyTake advantage of unprecedented market momentum - Jammu Links News
What drives Zhengye Biotechnology Holding Limited stock priceAccelerated financial growth - Autocar Professional
Published on: 2025-07-23 07:29:59 - jammulinksnews.com
Is KIDZ a good long term investmentUnmatched market gains - Autocar Professional
What analysts say about Zhengye Biotechnology Holding Limited stockExplosive trading opportunities - jammulinksnews.com
Is Zhengye Biotechnology Holding Limited a good long term investmentTremendous wealth creation - jammulinksnews.com
Zhengye Biotechnology Holding Limited Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
Real estate distribution Passive income from salesReliable High Profit Alerts - Newser
How Aardvark Therapeutics Inc. stock performs during market volatilityFree VIP Investment Strategies - Newser
How Zhengye Biotechnology Holding Limited stock performs during market volatilityFree Investment Community - Newser
Why Indonesia Energy Corporation Limited stock attracts strong analyst attentionFree Sector Rotation Based Trading Opportunities - Newser
How Luxfer Holdings PLC stock performs during market volatilityFree Stock Market Strategy Classes - Newser
Why GSIW stock attracts strong analyst attentionLow Risk Trade Timing Signals - Newser
Zhengye Biotech Earnings: Revenue Falls 12% as Company Pivots to Pet Vaccines with Exclusive Drug Approvals - Stock Titan
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Down 6% – Time to Sell? - Defense World
Ulta Beauty Posts Upbeat Results, Joins Unity Software, GATX And Other Big Stocks Moving Higher On Friday - Benzinga
Zhengye Biotechnology Receives NASDAQ Delinquency Notice for Late Filing - TipRanks
Zhengye Biotechnology faces NASDAQ compliance issue By Investing.com - Investing.com Nigeria
Zhengye Biotechnology faces NASDAQ compliance issue - Investing.com
Zhengye Biotechnology Holding Limited Receives NASDAQ Delinquency Letter for Non-Compliance with Listing Requirements - Nasdaq
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Finanzdaten der Zhengye Biotechnology Holding Ltd-Aktie (ZYBT)
Es liegen keine Finanzdaten für Zhengye Biotechnology Holding Ltd (ZYBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):